• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Dec. 9

    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study

    Everly Health Releases At-Home Collection Kidney Health Test

    Kenco Adds Two to its Life Sciences Division Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    BMP Medical

    maxon

    Providence Enterprise USA Inc.

    Halkey-Roberts Corporation

    Arthur G Russell Company, The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    BMP Medical

    maxon

    Providence Enterprise USA Inc.

    Halkey-Roberts Corporation

    Arthur G Russell Company, The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Hand-in-Hand with Quality and (Regulatory) Changes

    Greenlight Guru’s founder speaks with MPO about the firm’s FDA-connected initiatives and the changing regulatory landscape.

    Hand-in-Hand with Quality and (Regulatory) Changes
    Greenlight Guru’s True Quality Roadshow is an effort to promote the FDA’s Case for Quality initiative. Images courtesy of Greenlight Guru.
    Sean Fenske, Editor-in-Chief04.03.19
    There’s a great amount of concern among many in the industry over the revisions hitting the medical device regulatory sector all around the same time. Keeping tabs on the numerous changes, which ones will impact your company and products, and how to adjust to remain complaint can certainly be overwhelming. As such, it’s important to maintain close partners whose sole mission is to ensure everything that needs to happen does and in a timely manner.
     
    With this in mind, I reached out to Jon Speer, founder and vice president of QA/RA at Greenlight Guru. His firm offers a quality management system that’s specifically developed for the medical device industry. I asked him about his company, his insights on the coming regulatory changes, and the story behind his collaboration with the FDA.
     
    Sean Fenske: Please tell me about Greenlight Guru. What do you do?

    Jon Speer is the founder and vice president of QA/RA at Greenlight Guru.
    Jon Speer: Greenlight Guru is the first, and only medical device quality management system (MDQMS). QMSs have existed in a wide range of formats for quite some time; however, Greenlight Guru is the first to embrace cloud technology to develop a quality management system specifically designed to meet the unique needs of the medical device industry. We have developed a suite of pre-market, post-market, and consultative solutions, backed by the latest technology and regulatory compliance tools.
     
    Fenske: I know you could get different responses depending upon who you ask, but in your opinion, what is the most pressing regulatory issue for the industry?
    Speer: It's a little cliché, but change is constant. And this is especially true for the medical device industry. If we look at the past few years, we've had some significant changes to the regulatory landscape and on a global scale—like ISO 13485:2016, MDSAP, and now with the new MDR. Any one of these would be a huge undertaking for any company, let alone multiple happening at once.
     
    If you combine all of these very significant changes together, it's pretty daunting for a lot of companies. And we don't know what's going to happen in 2020—or the rest of 2019, for that matter. There's been ongoing talk about FDA’s plans to move away from their quality system regulation that’s been in place for more than 20 years—21 CFR Part 820—and adopting the globally harmonized standard of ISO 13485. I think it's time for companies to really consider how nimble they can be from a systems approach to be able to easily adapt to these changes.
     
    Fenske: Speaking of the new standard in the EU, what are the biggest challenges for companies seeking to comply with the new MDR?
    Speer: At this point, companies don’t know what resources are going to be available from auditing organizations or from notifying bodies. At this time, there is only one notified body that has been through the proper process and approved by the European Commission to conduct conformity assessments and issue CE mark certificates.
     
    One notified body is not going to have the capacity to keep up with the demands of the marketplace, and we're a little less than a year and a half to go before the deadline of the new MDR that will go into effect. Unfortunately, the EU has been very clear that there's no grandfather clause. I think the challenge is going to be, “Are there going to be enough notified body resources to keep up with the demand for the products that are seeing a profit margin in Europe?” My concern is that there is probably not.
     
    Fenske: With regard to potential regulatory changes in 2019, 2020, or beyond, what are your thoughts on the 510(k) Modernization announcement?
    Speer: I don't know if it's serendipity; I don't know if it's intentional, but everything that has been coming from FDA mid-2018 to present has been about trying to be more accommodating to medical device companies and trying to figure out more predictable ways for them to get to market. Some people say there's not a lot that's new here. But I think what we should take from the communication from FDA is that they are very keen to work with the medical device industry on streamlining processes in order to bring new products to market as fast as possible. FDA is much more progressive today, and much more interested in trying to collaborate and partner with industry stakeholders versus being the gatekeeper.
     
    Fenske: If the FDA is going to make changes to the regulatory pathway, where should they be focused?
    Speer: Many of the things we heard from FDA in the latter part of 2018 were about the 510(k) process, which makes sense because Class II is the most common designation for a medical device to gain 510(k) market clearance.
     
    We’ve also heard a great deal on De Novo clearances. Before De Novo, the lack of a predicate device would be the kiss of death for many companies due to the time and expense associated with getting a Class III device to market. De Novo allows devices that have a risk profile closer to a Class II device to get to market faster. FDA has done substantial work on the De Novo program to encourage both innovation and device quality, and I think more companies will utilize this route as their regulatory pathway of choice.
     
    Companies like Apple made progress last year when debuting their own medical device, leveraging the De Novo pathway. I think we'll see other companies—including non-traditional medical device companies—do the same sort of thing, bringing new, exciting technology into the healthcare space.
     
    Fenske: Do you think we need a timeline restriction on predicate devices as part of any 510(k) revisions?
    Speer: Predicate devices are a hot topic, especially after some documentaries have come out in the last year that have positioned predicate devices in a negative light.
     
    I would say, however, most modern regulatory professionals have not been using predicates that are older than 10 years. When I would put together 510(k) applications as an engineer and consultant, I wanted something as current as possible to use as a predicate. A device that has been cleared within the past couple years would give you a pretty good indication as far as what the FDA’s expectations are. There is a risk as a regulatory professional in picking an older predicate because the best practices that are in place at FDA evolve over time. So, if you pick something that's 15-years-old and base your submission on that, you're setting yourself up for some challenges.
     
    I think it is appropriate the FDA has stated this is a best practice for a good regulatory professional; you should always try to pick the most recent, most relevant, most appropriate predicates for your 510(k) as you possibly can.
     
    Fenske: Last year, Greenlight Guru partnered with FDA on their Case for Quality program. Can you share the experience and goal of that initiative?
    Speer: Starting in 2011, FDA observed medical device manufacturers were slow to adopt certain technologies due to regulatory hurdles. Unfortunately, this resulted in poor quality products and processes because manufacturers were only focused on compliance. In the case of quality management systems, manufacturers were hesitant to adopt cloud-based solutions because of the perceived hurdles of testing and evaluation. As a by-product, their device quality—and their users—suffered; this is what actually led us to develop the Greenlight Guru software platform.
     
    Early on, the existence of the Case for Quality program wasn’t widely known within the industry—and even today, I don’t think it's as well-known as it should be. Partnering with the FDA on the Case for Quality to further educate the industry on device quality was a no-brainer. Whether or not companies formally enroll in the program, better understanding the appraisal method, areas of practice, and how you should monitor your products and your processes is vital to creating positive outcomes for patients and end users.
     
    Fenske: Most recently, Greenlight Guru has announced a True Quality Roadshow that will take place in 2019, with stops scheduled in eight cities. Can you tell me more about this initiative and why you’re doing it?
    Speer: We developed the True Quality Roadshow shortly after partnering with FDA to help promote the benefits of their Case for Quality initiative. The True Quality Roadshow furthers our mission to help improve the quality of life by helping device makers imagine, introduce, and advance higher quality devices faster, with less risk.
     
    Each stop of the True Quality Roadshow will include a networking event, a panel discussion with industry professionals, and discussions around the current state of the medical device industry, regulatory updates, and best practices in attaining “True Quality.”
     
    Fenske: While you have substantial initiatives already on your plate, what’s next for Greenlight Guru?
    Speer: FDA and the EU MDR have signaled that major changes are on the way. We will continue to focus our efforts on helping our users and medical device community stay abreast of the latest regulatory changes. Leveraging the latest technologies gives us the opportunity to implement innovative solutions within our quality system that will help maximize a product team’s visibility of possible sources of risks, before they occur.
    Related Searches
    • iso 13485:2016
    • fda
    • mdsap
    • greenlight.guru
    Related Knowledge Center
    • Software & IT
    Suggested For You
    FDA FDA's Material Evaluation—Mike on Medtech
    Study: Apple Watch May Help Flag Heart Rhythm Problems Study: Apple Watch May Help Flag Heart Rhythm Problems
    Going Beyond the Conversation in Addressing the Skills Gap Going Beyond the Conversation in Addressing the Skills Gap
    Saranas Saranas' Early Bird Bleed Monitoring System Gains De Novo Clearance
    510(k) Modernization—Mike on Medtech 510(k) Modernization—Mike on Medtech
    FDA OKs Hologic FDA OKs Hologic's Test to Detect Mycoplasma Genitalium STI
    J&J, Apple Seek to Improve AFib Outcomes J&J, Apple Seek to Improve AFib Outcomes
    FDA FDA's New Actions Concerning the Digital Health Pre-Cert Pilot Program
    Personalized Healthcare—Mike on Medtech Personalized Healthcare—Mike on Medtech
    Device to Objectively Assess Pressure Ulcer Risk Wins De Novo Clearance Device to Objectively Assess Pressure Ulcer Risk Wins De Novo Clearance
    Holiday Wish List, Part 2—Mike on Medtech Holiday Wish List, Part 2—Mike on Medtech
    Holiday Wish List, Part 1—Mike on Medtech Holiday Wish List, Part 1—Mike on Medtech
    The Regulatory Outlook for 2019 The Regulatory Outlook for 2019
    FDA Plans to Modernize 510(k) Program FDA Plans to Modernize 510(k) Program
    Images from Medica/Compamed 2018, Day 2 Images from Medica/Compamed 2018, Day 2

    Related Podcasts

    • Materials
      FDA

      FDA's Material Evaluation—Mike on Medtech

      Sean Fenske and Mike Drues discuss the FDA's announcement that the agency will review materials used in the manufacture of medical devices.
      Sean Fenske, Editor-in-Chief 04.02.19

    • Cardiovascular | Patient Monitoring
      Study: Apple Watch May Help Flag Heart Rhythm Problems

      Study: Apple Watch May Help Flag Heart Rhythm Problems

      The Apple Watch was able to detect AFib in a small group of people who had been alerted by the app as having an irregular heartbeat.
      American College of Cardiology 03.18.19

    • Going Beyond the Conversation in Addressing the Skills Gap

      Going Beyond the Conversation in Addressing the Skills Gap

      ...
      Sean Fenske, Editor-in-Chief 03.07.19


    • Cardiovascular | Patient Monitoring | Surgical
      Saranas

      Saranas' Early Bird Bleed Monitoring System Gains De Novo Clearance

      First and only device for real-time detection and monitoring of endovascular bleed complications.
      Business Wire 03.06.19

    • 510(k) Modernization—Mike on Medtech

      510(k) Modernization—Mike on Medtech

      Sean Fenske and Mike Drues discuss the potential changes coming to the 510(k) regulatory pathway and examine the issues around predicate devices.
      Sean Fenske, Editor-in-Chief 01.25.19

    Loading, Please Wait..

    Breaking News
    • MPO's Most-Read Stories This Week—Dec. 9
    • Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    • WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    • Everly Health Releases At-Home Collection Kidney Health Test
    • Kenco Adds Two to its Life Sciences Division Team
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    MSM Linked to Improvements in Knee Pain
    Coatings World

    Latest Breaking News From Coatings World

    Weekly Recap: PPG, PPG Asian Paints, AkzoNobel Top This Week’s Stories
    Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
    Peninsula Polymers Acquires New Distribution Center in Indiana
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Dec. 9
    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    Contract Pharma

    Latest Breaking News From Contract Pharma

    FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
    Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
    Innovent Biologics, Synaffix Expand ADC Licensing Deal
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
    Christian Louboutin Taps Morgane Martini as Global Makeup Artist
    Shiseido Forms New Venture Fund
    Happi

    Latest Breaking News From Happi

    Diya Beauty & Wellness Acquires WR Group's Retail Brands and North American Sales Division
    Pantone Color of the Year & A New CEO
    When It Comes to Bath and Body Rituals, Consumers Want The Works
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
    Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
    BASF Commits to Scope 3.1 Emissions Targets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Analyzing the Russian label market, Carter boosts brands and more
    FLAG’s December Lunch & Learn to feature Omet
    UPM Raflatac releases neuromarketing study findings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: New Dates for INDEX 26, Campen Announces Patent Pending Status for Airlaid Trays
    Ginni Strikes Deal to Sell Spinning, Knitting Operations
    Campen Machinery Announces Patent Pending Status for Airlaid Trays
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Dec. 9
    Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
    Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories
    Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
    Ciena Invests in US Manufacturing with Flex

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login